Tag: large hemispheric infarction
Remedy announces US FDA orphan drug designation to treat large-territory acute...
Remedy Pharmaceuticals has announced that the US Food and Drug Administration (FDA) Office of Orphan Products Division (OOPD) has granted orphan drug designation to...
Remedy announces Phase 3 CHARM trial data indicating Cirara’s potential in...
Remedy Pharmaceuticals recently announced promising new data from the Phase 3 CHARM clinical trial of Cirara (intravenous glyburide) in patients with large hemispheric infarction (LHI)—a...
